CTLA-4

Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
Eileen Shiuan, Kathryn E. Beckermann, Alpaslan Ozgun, Ciara Kelly, Meredith McKean, Jennifer McQuade, Mary Ann Thompson, Igor Puzanov, John P. Greer, Suthee Rapisuwon, Michael Postow, Michael A. Davies, Zeynep Eroglu, Douglas Johnson

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 8; DOI: 10.1186/s40425-017-0210-0
Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer
Raju R Raval, Andrew B Sharabi, Amanda J Walker, Charles G Drake, Padmanee Sharma

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 14; DOI: 10.1186/2051-1426-2-14
Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes
Karsten A Pilones, Joseph Aryankalayil, James S Babb, Sandra Demaria

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 37; DOI: 10.1186/s40425-014-0037-x

Main menu